glucagon glp-1 Glucagon-like peptide-1: Trends in Endocrinology & Metabolism Frontiers | GLP-1R in diabetes

Accordingly, GLP-1 should be regarded as a heuristic example rather than a prescriptive template for all peptide therapeutics

And it certainly is going to take longer than two months to get to the health status that would allow for you to sustain that new weight without the drug. That sentence is basically this whole article

Below is a summary (definitely not exhaustive) for the landscape of weight loss drugs in development (including company name and formulation, dosing and mechanism), showing my estimation of when these could launch and become available for patients

Understanding the established side effect profile of semaglutide provides important context when evaluating less commonly reported symptoms, such as leg cramps, which patients may experience during treatment